BioSpace
FDA’s Top Cancer Regulator Declined CDER Directorship
The search continues for a new leader for the FDA’s Center for Drug Evaluation and Research after George Tidmarsh resigned on ...
White House backs FDA head after ouster of top regulator
The administration, as well as HHS, publicly praised Marty Makary’s leadership despite persistent upheaval at the agency.
FDA Commissioner Dr. Marty Makary on streamlining approvals for biosimilar generic drugs
FDA Commissioner Dr. Marty Makary joins 'Squawk Box' to discuss plans to speed up the approval of biosimilar generic drugs in ...
FDA to streamline approvals for generic biological drugs in latest move targeting health costs
The US Food and Drug Administration will take steps to streamline the process to develop generic versions of complex biological drugs, the agency announced Wednesday. The changes are meant to ...